4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001104659-25-014744
Options or other derivatives
- Chief Operating Officer acquired 500,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Longcor Jarrod Chief Operating Officer | 2025-02-14 | Grant or award · Stock option (right to buy) | +500,000 | 500,000 | D | ||
Loading xslF345X05/tm256830-5_4seq1.xml…